Vimarsana
Biggest News Aggregation in the World

Page 44 - First North News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from First North. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In First North Today - Breaking & Trending Today

Investegate |Faron Pharma. Oy Announcements | Faron Pharma. Oy: Proposed Issue and Placing - Vimarsana News

Investegate |Faron Pharma. Oy Announcements | Faron Pharma. Oy: Proposed Issue and Placing

Investegate announcements from Faron Pharma. Oy, Proposed Issue and Placing

Nasdaq, Inc. (NASDAQ:NDAQ) Q4 2022 Earnings Call Transcript - Vimarsana News

Nasdaq, Inc. (NASDAQ:NDAQ) Q4 2022 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Nasdaq Fourth Quarter 2022 Results Conference Call. At this time, all participants are in a listen-only mode.

First North Korean Extradited to US Is Sentenced - Vimarsana News

First North Korean Extradited to US Is Sentenced

Washington - The first North Korean national ever to be extradited to the United States has been sentenced for money laundering. Businessman Mun Chol My

Nasdaq Stockholm AB: Listing of subscription rights and paid subscription shares of LIDDS AB (46/23) - Vimarsana News

Nasdaq Stockholm AB: Listing of subscription rights and paid subscription shares of LIDDS AB (46/23)

With effect from January 23, 2023, the subscription rights in LIDDS AB will be traded on First North Growth Market. Trading will continue up until and including February 01, 2023. Instrument: Subscription

Nasdaq Stockholm AB: Listing of subscription units and paid subscription units of Bonzun AB (42/23) - Vimarsana News

Nasdaq Stockholm AB: Listing of subscription units and paid subscription units of Bonzun AB (42/23)

With effect from January 20, 2023, the subscription units in Bonzun AB will be traded on First North Growth Market. Trading will continue up until and including January 31, 2023. Instrument: Subscription